Duck Flats Pharma

Duck Flats Pharma is a private biotechnology company founded by the leadership team behind Aduro Biotech, led by Chairman and CEO Stephen T. Isaacs. Based in the San Francisco Bay Area, the company is focused on developing a new class of medicines for the treatment of oncology and rare genetic diseases. While maintaining a relatively low profile, Duck Flats Pharma leverages the extensive expertise of its founding team in immunotherapy and live biotherapeutic technologies. The company is currently in the discovery and pre-clinical stages, aiming to translate complex biological mechanisms into transformative clinical therapies. Its mission centers on addressing significant unmet medical needs through innovative synthetic biology and advanced drug delivery approaches.